ADA (8C3) Monoclonal Antibody
Applications
Reactivity
| Overview | |
| Catalog # | bsm-51447M |
| Product Name | ADA (8C3) Monoclonal Antibody |
| Applications |
WB
|
| Reactivity | Human |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Mouse |
| Source | This ADA antibody is generated from mice immunized with a KLH conjugated synthetic peptide between 287-314 amino acids from the C-terminal region of human ADA. |
| Clonality | Monoclonal |
| Clone # | 8C3 |
| Isotype | IgG1 |
| Concentration | Lot Dependent |
| Purification | Purified by Protein G. |
| Storage Buffer | 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Store at -20°C for 12 months. |
| Target | |
| Gene ID | 100 |
| Swiss Prot | P00813 |
| Synonyms | Adenosine deaminase; Adenosine aminohydrolase; ADA; ADA1 |
| Background | Catalyzes the hydrolytic deamination of adenosine and 2-deoxyadenosine. Plays an important role in purine metabolism and in adenosine homeostasis. Modulates signaling by extracellular adenosine, and so contributes indirectly to cellular signaling events. Acts as a positive regulator of T-cell coactivation, by binding DPP4. Its interaction with DPP4 regulates lymphocyte-epithelial cell adhesion. |
| Application Dilution | |
| WB | 1:500-2000 |
Frequently asked questions
Which applications is ADA (8C3) Monoclonal Antibody (bsm-51447M) validated for, and at what dilution?
bsm-51447M is validated for WB (1:500-2000). These are recommended starting dilutions; optimal dilutions should be determined by the end user.
Which species does ADA (8C3) Monoclonal Antibody (bsm-51447M) react with?
Tested reactivity: Human.
How should bsm-51447M be stored?
Store at -20°C for 12 months. Storage buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
What immunogen was used to raise ADA (8C3) Monoclonal Antibody (bsm-51447M)?
This ADA antibody is generated from mice immunized with a KLH conjugated synthetic peptide between 287-314 amino acids from the C-terminal region of human ADA.